Waters Corp Announces Strategic Partnership with Becton Dickinson

Waters Corp has entered into a significant agreement with Becton Dickinson, under which a unit of Becton Dickinson will be merged with Waters’ Biosciences & Diagnostic Solutions division.

The merger is expected to create a leading company in the bioscience and diagnostics sector, enhancing Waters’ presence in multiple growth areas. The combined entity is anticipated to benefit from Waters’ established execution model, providing immediate commercial benefits.

Key highlights of the deal include:

• The combined entity is expected to have a pro-forma revenue of around $6.5 billion for 2025.
• The merger is expected to create a leading company in the bioscience and diagnostics sector.

However, the stock price of Waters Corp has dropped by around 12% following the announcement, likely due to investors’ concerns about the risks associated with the deal.